PARIS: French pharmaceutical giant Sanofi on Monday (May 25) said it planned to divest its stake in US biotech firm Regeneron which is valued at around US$13 billion. Sanofi, which holds around 20.6 per cent in Regeneron, however insisted it had no intention of halting its partnership with the …
